Research from Marcela Maus’ laboratory, presented at the 2021 American Society of Hematology (ASH) meeting, identified a soluble variant of the CD70 ligand, CD27, as a factor that could reduce the effectiveness of CD70-CAR-T cells in AML co-cultures [292]. This evidence concerns the gene CD70 and acute myeloid leukemia.